Amplifying Data Science Tools for End-to-End eClinical Solutions with Andreas Weber, Group CEO at EvidentIQ

Andreas Weber, Group CEO, EvidentIQ, discusses hybrid vs. fully decentralized trials, the use of real-world evidence (RWE) in clinical trials, and how an end-to-end eClinical solution can help meet increasing customer demand across clinical operations and clinical data management, plus much more!

To find out more about Impetus: https://www.meetwithimpetus.com

Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/

Impetus Digital Website: https://www.impetusdigital.com/

Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/

Impetus Digital Twitter: https://twitter.com/impetus_digital

Impetus YouTube: https://www.youtube.com/ImpetusDigital

Andreas Weber: https://www.linkedin.com/in/andreas-weber-916aa140/

EvidentIQ: https://www.evidentiq.com/ 

Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity.

Click the social media buttons to share this episode with your network!

To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.com

Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/

Impetus Digital Website: Home Page

LinkedIn: https://www.linkedin.com/company/impetus-digital/

Twitter: impetus_digital

YouTube: Impetus Digital